Preferred Name |
ralimetinib |
Synonyms |
3-(2,2-Dimethylpropyl)-5-(4-(4-fluorophenyl)-2-(2-methyl-2-propanyl)-1H-imidazol-5-yl)-3H-imidazo(4,5-b)pyridin-2-amine |
ID |
http://purl.bioontology.org/ontology/MESH/C580958 |
altLabel |
3-(2,2-Dimethylpropyl)-5-(4-(4-fluorophenyl)-2-(2-methyl-2-propanyl)-1H-imidazol-5-yl)-3H-imidazo(4,5-b)pyridin-2-amine LY2228820 dimesylate LY2228820 3H-Imidazo(4,5-b)pyridin-2-amine, 5-(2-(1,1-dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)- |
cui |
C4519218 C3659483 C3661088 |
HM |
D011725 D007093 |
II |
D048308/Q000037 |
Inverse of RB |
73I34XW4HD |
Mapped to | |
MDA |
20130508 |
MeSH Frequency |
15 |
MMR |
20210916 |
notation |
C580958 |
prefLabel |
ralimetinib |
SC |
1 |
Scope Statement |
structure in first source |
SRC |
Br J Haematol. 2008 May;141(5):598-606. |
TERMUI |
T001111680 T001111681 T843871 T843872 T001111682 |
TH |
NLM (2013) NLM (2021) |
tui |
T109 T121 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C143046 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |